Skip to main content

ProtoKinetix, Inc.

PKTX
Industry
Pharmaceutical Preparations
SEC CIK
0001128189

No open-market purchases or sales by ProtoKinetix, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $200 in total; no superinvestor holds it.

Holders of 5% or more of PKTX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of ProtoKinetix, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of ProtoKinetix, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

12 Schedule 13D and 13G filings on ProtoKinetix, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on PKTX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jun 17, 2024Smith Clarence Edward13D/AOld format–––SEC
Dec 28, 2023Smith Clarence Edward13D/AOld format–––SEC
Jun 15, 2023Smith Clarence Edward13D/AOld format–––SEC
Feb 15, 2023Young Lachlan Grant13G/AOld format–––SEC
Feb 15, 2023Smith Alexandra Blake13G/AOld format–––SEC
Feb 15, 2023Smith Clarence Edward13D/AOld format–––SEC
Mar 21, 2022Smith Clarence Edward13D/AOld format–––SEC
Mar 21, 2022Young Lachlan Grant13G/AOld format–––SEC
Mar 21, 2022Smith Alexandra Blake13G/AOld format–––SEC
Aug 6, 2021Smith Clarence Edward13D/AOld format–––SEC
Aug 6, 2021Young Lachlan Grant13G/AOld format–––SEC
Aug 6, 2021Young Lachlan Grant13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell ProtoKinetix, Inc. shares.

No Form 144 notices for ProtoKinetix, Inc. are on file.